Vizantin is an insoluble adjuvant that activates macrophages and lymphocytes. Recently, 2,2 0 ,3,3 0 ,4,4 0 -hexasulfated-vizantin (sulfated vizantin), which enables solubilization of vizantin, was developed by the present team. Sulfated vizantin was found to enhance bactericidal activity against multi-drug resistant Pseudomonas aeruginosa in RAW264.7 cells. In addition, spread of P. aeruginosa was inhibited in RAW264.7 cells treated with sulfated vizantin. When only sulfated vizantin and P. aeruginosa were incubated, sulfated vizantin did not affect growth of P. aeruginosa. Formation of DNA-based extracellular traps (ETs), a novel defense mechanism in several types of innate immune cells, helps to eliminate pathogens. In the present study, ET-forming macrophages constituted the majority of immune cells. Sulfated vizantin induced ET formation in RAW264.7 cells, whereas a Ca-chelating reagent, EDTA, and T-type calcium channel blocker, tetrandrine, inhibited ET formation and attenuated inhibition of spread of P. aeruginosa in sulfated vizantin-treated cells. Thus, sulfated vizantin induces ET formation in phagocytic cells in a Ca-dependent manner, thus preventing spread of P. aeruginosa. Hence, sulfated vizantin may be useful in the management of infectious diseases.
We previously developed vizantin through a structurefunction relationship study with trehalose- 6, 6 0 -dimycolate extracted from Mycobacterium tuberculosis (1, 2) . Similarly to LPS, vizantin activates the innate immune response through specific binding with the TLR4/MD2 protein complex (1); however, it does not induce TNF production as LPS does (1, 2) . TNF production results in serious complications such as cytokine storms (3) . Our previous findings suggest that vizantin contributes minimally to immunotoxicity. Furthermore, vizantin competes with LPS for TLR4 binding, suggesting that it may be a safe therapeutic agent for endotoxemic phenomena, including sepsis-like symptoms and septic shock (1) . However, the pharmacokinetics of vizantin is limited because it is hydrophobic. Recently, we overcame this limitation by sulfating vizantin, thereby making it hydrophilic.
Extracellular trap formation is a recently described innate immune response to infection. ETs serve as physical barriers and induce immune responses to infections in certain immune cells, including neutrophils, macrophages, mast cells and eosinophils (4) (5) (6) . ETs comprise elastase, myeloperoxidase, cathepsin G and defensins, DNA and histones constituting their backbones (5, 6) . ETs trap and kill various microbes, including Staphylococcus aureus, Streptococcus pyogenes, Vibrio cholerae, Candida albicans, Aspergillus fumigatus, Leishmania amazonensis and influenza virus (5, 6) . Numerous studies have reported the stimuli for ET formation in neutrophils; however, few reported studies have investigated them for macrophages (5) . The mechanism underlying ET formation in neutrophils differs from that in macrophages (6) . LPS or PMA trigger ET formation in neutrophils, but not in macrophages (5, 7) . Recent studies have reported that the murine RAW264.7 macrophage cell line and peritoneal macrophages produce ETs in response to statin or TNF stimulation (8, 9) . Furthermore, macrophages in human blood that have been differentiated from peripheral blood monocytes also reportedly release ETs on exposure to M. tuberculosis (10) . Therefore, the present study aimed to investigate the effect of vizantin or watersoluble vizantin, (i.e., sulfated vizantin), an analog of trehalose-6,6
0 -dimycolate in M. tuberculosis, on ET formation in macrophages.
MATERIALS AND METHODS

Reagents
Tetrandrine, EDTA and nifedipine were purchased from Merck Millipore (Darmstadt, Germany), CFSE from Thermofisher Scientific (Waltham, MA, USA), pyridinesulfur trioxide complex from Tokyo Chemical Industries (Tokyo, Japan), N,N-dimethylformamide from Wako (Osaka, Japan), triethylamine from Nacalai Tesque (Kyoto, Japan), methanol from Kanto Chemical (Tokyo, Japan) and Sephadex LH-20 beads and Sephadex G-25 Superfine from GE Healthcare Bio-sciences (Uppsala, Sweden), Amberlite IR120Na from Sigma-Aldrich (St. Louis, USA). All other drugs were of analytical grade, unless specified otherwise.
Preparation of sulfated vizantin
Vizantin was prepared according to the reported procedure for synthesis (2) A mixture of vizantin (100 mg, 104 mmol) and pyridine-sulfur trioxide complex (2 g, 18.8 mmol) in N,N-dimethylformamide (10 mL) was stirred for 4 hrs at 25°C. Triethylamine (8 mL) and methanol (10 mL) were then added to the mixture, followed by direct filtration using Sephadex LH-20 beads (GE Healthcare Bio-sciences). The filtrate was concentrated under reduced pressure, the residue dissolved in 10 mL of H 2 O, and the resulting solution stirred in the presence of an ion-exchange resin (Amberlite IR120Na; Sigma-Aldrich) for 30 min (2, 11 
Bacterial strains
The bacterial strains used in this study were P. aeruginosa strain 13-226, a multidrug-resistant strain isolated from a critically ill patient at Niigata Prefectural Shibata Hospital in Shibata City in Japan and P. aeruginosa strain PAO1 (ATCC15629; Dainippon Sumitomo Pharma, Osaka, Japan). P. aeruginosa bacteria were cultured in LB broth (Nippon Becton Dickinson, Tokyo, Japan) at 37°C to the mid-log phase. P. aeruginosa were harvested by centrifugation at 5000 rpm for 10 min, washed once with PBS and diluted to the required density.
Cell culture
RAW264.7 cells (Dainippon Sumitomo Pharma) were grown in Dulbecco's modified Eagle's medium (Wako) supplemented with 10% FBS (Japan Bio Serum, Hiroshima, Japan), 100 U/mL penicillin (Wako), and 100 mg/mL streptomycin (Wako) at 37°C in 5% CO 2 .
Bactericidal assays
RAW264.7 cells were treated with or without various concentrations of sulfated vizantin for 60 min at 37°C in 5% CO 2 . The cells were incubated with P. aeruginosa (MOI:1) for 4 hrs. Following bactericidal assay, the cells were lysed with Triton X-100 (Nacalai Tesque) and plated onto LB agar (Nippon Becton Dickinson) plates to quantitate the surviving bacteria in terms of their CFUs. The percent killing of sulfated vizantin-treated cells was determined by dividing the number of CFU recovered from the sulfated vizantintreated cells by the number of CFU recovered from vehicle control-treated cells.
Phagocytosis assay
After stimulation of RAW264.7 cells with various concentrations of sulfated vizantin for 60 mins, the cells were incubated with CFSE-labeled P. aeruginosa PAO1 (MOI:1) for 60 min at 37°C in 5% CO 2 . The cells were incubated with Dulbecco's PBS (Thermofisher Scientific) containing 100 mg/mL gentamycin (Wako) for 30 min and then washed with Dulbecco's PBS three times. The fluorescent intensity of CFSE-labeled P. aeruginosa was analyzed by fluorescent microscopy (Biorevo BZ-9000; Keyence, Osaka, Japan) and the associated analysis software package (BZ-H2A).
Bacteria spreading assay
Transwells (Chemotaxicell 96; Kurabo, Okayama, Japan) were used for bacterial spreading. RAW264.7 cells were seeded on transwells at a density of 2 Â 10 4 cells/filter. The upper and lower chambers were filled with Dulbecco's Modified Eagle's medium. The cells on the filters were treated with sulfated vizantin at various concentrations at 37°C for 60 min, followed by incubation with P. aeruginosa at an MOI of 1 for 60 min at 37°C. Medium in the lower chamber was diluted and plated on LB agar plates.
Growth curve experiments
For pre-treatment experiments, log-phase P. aeruginosa bacteria were incubated for 30 min in the presence of 50 mM sulfated vizantin or a saline vehicle control. For growth curve analysis, mid-log-phase P. aeruginosa cells were diluted 100Â in Roswell Park Memorial Institute 1640 medium (Wako) in the presence or absence of 50 mM sulfated vizantin and incubated at 37°C in 5% CO 2 . Bacterial density (OD at 620 nm) was measured hourly.
Staining of ETs
To stain the ETs of sulfated vizantin-treated RAW264.7 (Matsunami, Osaka, Japan), the cells were fixed with 4% paraformaldehyde on a film-bottom dish and blocked with blocking solution (Thermofisher Scientific). The samples were stained with a polyclonal rabbit anti-histone H4 citrulline 3 antibody (1:100; #07-596; Millipore). The samples were then washed and incubated with Alexa546-conjugated rabbit IgG, after which they were incubated with SYTOX green or SYTOX orange (Thermofisher Scientific), which is a nucleic acid stain reagent, for 30 min at 25°C. The dishes were washed and mounted using Vectashield (Vector Laboratories, Cambridgeshire, UK). As a negative control, duplicate dishes were treated with control rabbit IgG (Sigma-Aldrich) at the appropriate concentrations. ET structures were assessed using a confocal laser scanning microscope (LSM800, Zeiss, Jena, Germany).
Enumeration of ET-forming cells
To enumerate ET-forming cells stained with SYTOX green, the total numbers of macrophages and ET-forming cells per microscopic field of view were determined in 20 individual images of each sample. In total, 200 cells were counted for each sample. DNA-releasing cells were considered ET-producing cells and each ET structure was considered to have been released by one macrophage.
Statistical analysis
Data were analyzed using GraphPad Prism 6.05 (GraphPad Software; La Jolla, CA, USA). All data are presented as the mean AE SD. Mean values were compared between experimental groups using Dunnett's test and Student's t-test and differences with P < 0.05 were considered statistically significant.
Results
Sulfated vizantin induces phagocyte antimicrobial activity
We investigated the effect of in vitro stimulation with sulfated vizantin on the ability of RAW264.7 cells to kill P. aeruginosa. Sulfated vizantin-pretreatment significantly increased the bactericidal activity of RAW264.7 cells in a dose-dependent manner (Fig. 1a) . Furthermore, we used CFSE-labeled P. aeruginosa PAO1 to investigate the phagocytic activity of RAW264.7 cells treated with sulfated vizantin. Sulfated vizantin treatment enhanced the phagocytic activity of RAW264.7 cells, suggesting induction of a generalized mechanism for bacterial killing (Fig. 1b) .
Spread of P. aeruginosa is inhibited in sulfated vizantin-treated RAW264.7 cells
We examined the effect of sulfated vizantin on the spread of P. aeruginosa infection in chemotaxis wells (Fig. 2a) . Sulfated vizantin dose-dependently inhibited spread of P. aeruginosa from the upper chamber to lower chamber (Fig. 2b) ; however, it did not affect bacterial growth (Fig. 2c) .
Sulfated vizantin induces ET formation in macrophages
Furthermore, we investigated the effect of sulfated vizantin on ET formation in sulfated vizantin-treated RAW264.7 cells. The cells were stained with SYTOX green and an antibody against Histone H4 citrulline 3, an ET marker in macrophages (3, 9, 12) . Sulfated vizantintreated cells released DNA and a SYTOX green-positive extracellular region was visualized by immunostaining with anti-Histone H4 citrulline 3 antibody (Fig. 3a) . However, the results for LPS-or PMA-treated cells were similar to those of the control cells (Fig. 3b) . Production of SYTOX green-stained ETs from RAW264.7 cells treated with sulfated vizantin was approximately 8.2-fold greater than that produced by control cells (Fig. 3b) . In addition, fluorescent images showed that P. aeruginosa co-localizes with ETs from RAW264.7 cells treated with sulfated vizantin, indicating that ETs entrap microbes (Fig. 3c,d ).
Calcium ions are involved in ET formation in RAW264.7 cells
Ca ions are known to play an important role in ET formation (3, 12) . We investigated the relationship between ET formation induced by sulfated vizantin and that induced by Ca ions. We found that a Ca-chelating reagent, EDTA, and T-type calcium channel blocker, tetrandrine, inhibit ET formation induced by sulfated vizantin; however, L-type calcium channel blocker nifedipine does not (Fig. 4a) . In the bacteria spreading assay, EDTA and tetrandrine attenuated inhibition of bacterial spread in sulfated vizantin-treated RAW264.7 cells (Fig. 4b) .
DISCUSSION
Since 2005, ET formation has been known to play an important role in combating infections by invading pathogens. The present findings show that sulfated vizantin promotes bacterial killing without directly affecting P. aeruginosa growth and induces ET formation with Histone H4 citrulline 3 in RAW264.7 cells in a Ca ion-dependent manner. Several chemical stimuli, such as PMA and LPS, are effective inducers of ET formation in neutrophils (4, 13, 14) . LPS reportedly induces ET formation in neutrophils or eosinophils pre-treated with certain cytokines (15, 16) . Liu et al. have reported that PMA and LPS do not lead to ET formation in either murine macrophage cell lines or peritoneal macrophages (7).
These results suggest that the mechanisms underlying LPS-and MPA-induced ET production differ between neutrophils and macrophages. The present findings indicate that sulfated vizantin is a more effective stimulant of formation of ETs than PMA and LPS (Fig. 3a) . In addition, we stained ETs with anti-histone H4 citrulline 3 antibody. PAD2 is known to catalyze histone citrullination in ET-forming macrophages (3, 17) . Hence, ET formation in sulfated vizantin-treated RAW264.7 cells probably depends on PAD2-mediated histone citrullination.
Ca ion influx induces PAD2 activation and stimulates small conductance potassium channels and mitochondrial ROS generation, resulting in induction of ET formation in neutrophils (18, 19) . In the present study, a Ca ion-chelating reagent, EDTA, and T-type calcium channel blocker, tetrandrine, inhibited ET formation; however, an L-type calcium channel blocker, nifedipine, did not (Fig. 4a) . These results indicate that Ca influx via T-type calcium channels plays an important role in ET formation in sulfated vizantin-treated RAW264.7 cells.
We found that sulfated vizantin enhances phagocytic activity against P. aeruginosa (Fig. 1) . The spread of P. aeruginosa infection was inhibited in sulfated vizantintreated RAW264.7 cells (Fig. 2b) , suggesting that sulfated vizantin-activated macrophages trap and phagocytize these bacteria. Statins, which inhibit 3-hydroxy 3-methylglutaryl coenzyme A reductase, reportedly boost production of antibacterial DNA-based ETs in human and murine neutrophils and monocytes/macrophages (8) . Data from recent clinic-epidemiological studies have indicated a correlation between statin therapy and reduced mortality from severe bacterial infection (8, (20) (21) (22) (23) (24) (25) (26) (27) . Therefore, ET inducers such as sulfated vizantin may serve as potent drugs for managing infections and supplementing the effects of antibiotics.
In summary, the findings of the present study indicate that sulfated vizantin is a novel agent for inducing ET formation. However, the mechanism underlying ET formation is unclear. Further studies are required to elucidate the association between sulfated vizantin and induction of ET formation. 
